CareFusion to buy pharma tech company

Justine Varieur Cadet | | Health Imaging | Enterprise Imaging
CareFusion has signed an agreement to acquire Phacts, a Seattle-based technology and consulting company that seeks to help hospital pharmacies manage inventory, reduce pharmaceutical costs and streamline operations. Terms of the deal were not disclosed.

In November 2010, CareFusion announced a marketing relationship as the exclusive reseller of Phacts pharmacy inventory management software and automation. Through this partnership, Phacts expanded its base of customers by 50 percent to more than 200 customers, according to the San Diego-based CareFusion.

Phacts products include both software and automation technologies for health systems and hospital pharmacies, and its portfolio includes:
  • Pharmogistics pharmacy inventory management software, which operates carousel hardware for medication storage and retrieval in the hospital pharmacy;
  • PharmoPack medication packaging and barcode labeling system for oral drugs in solid form; and,
  • PharmoCode barcode labeling system for non-oral medications and devices, such as vials and syringes.

Subject to customary conditions, the acquisition is expected to close in the fourth quarter of CareFusion fiscal year 2012. The company said its acquisition is expected to be neutral to adjusted earnings in the first year and increasingly accretive thereafter.

Justine Varieur Cadet

Related Content

Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.